Company Search:
Advanced Search
Sponsored Links
Adimmune Corporation Company Snapshot
Adimmune Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adimmune with three other pharmaceutical manufacturers in Asia: ISU Abxis Company Limited of South Korea (2015 sales of 11.47 billion Korean Won [US$10.09 million] of which 100% was Antibody Medicine), Viromed Company Ltd of South Korea (7.70 billion Korean Won [US$6.77 million] ), and Tego Science Inc which is also based in South Korea (7.49 billion Korean Won [US$6.59 million] ).

Sales Analysis. Adimmune reported sales of 290.74 million Taiwanese Dollars (US$9.16 million) for the year ending December of 2015. This represents a sharp decrease of 39.5% versus 2014, when the company's sales were 480.51 million Taiwanese Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adimmune Corporation
  Stock Performance Chart for Adimmune Corporation
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 23.00
(Figures in Taiwanese Dollars)
1 Week 1.1%   13 Weeks 0.2%  
4 Weeks -4.2%   52 Weeks -5.3%  
Adimmune Corporation Key Data:
  Ticker: 4142 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 290,737,000
(Year Ending Jan 2016).
Employees: 276
  Currency: Taiwanese Dollars Market Cap: 5,380,114,000
  Fiscal Yr Ends: December Shares Outstanding: 233,918,000
  Share Type: Gu Closely Held Shares: 61,473,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.